Valeo Pharma Inc. (VPHIF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Feb 11, 2026

Valeo Pharma Company Description

Valeo Pharma Inc. operates as a pharmaceutical company focused on licensing, acquiring, and commercializing drugs.

The company provides commercialized pharmaceutical products in Canada, with a focus on respiratory/allergy, ophthalmology, and specialty therapeutic areas.

It licenses and acquires Canadian rights to commercial-stage and proprietary drugs, managing registration and commercialization through all stages.

The company offers access to product specialists and medical information for healthcare professionals and patients.

Valeo Pharma serves healthcare professionals, including Canadian physicians, and focuses on hospital specialty sectors.

The company was founded in 2003 and is based in Kirkland, Canada.

Valeo Pharma Inc.
Valeo Pharma logo
Country Canada
Founded 2003
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 70
CEO Al Moghaddam

Contact Details

Address:
16667 Hymus Boulevard
Kirkland, QC H9H 4R9
Canada
Phone (514) 694-0150
Website valeopharma.com

Stock Details

Ticker Symbol VPHIF
Exchange OTCMKTS
Share Class Class A Shares
Fiscal Year November - October
Reporting Currency CAD
ISIN Number CA91915B1085
SIC Code 2834

Key Executives

Name Position
Kyle Steiger Senior Vice President and Chief Commercial Officer
Pascal Tougas Chief Financial Officer
Frédéric Dumais Director of Communications and Investor Relations
Guy-Paul Allard Vice President of Legal Affairs and Corporate Secretary
Jean Francois Fournier Head of Ophthalmology Business Unit